Track topics on Twitter Track topics that are important to you
The foremost choice in the treatment of patients with newly diagnosed multiple myeloma is determining whether a patient is eligible for transplant, as that choice will set the stage for all future decisions.
Original Article: Daratumumab Becomes Treatment Staple in Newly Diagnosed Multiple MyelomaNEXT ARTICLE
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...